Profile
AVGR ISRG BDX BDXA ALC RMD
Company Name Avinger, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.52M $176.09B $65.60B $64.58B $45.56B $33.16B
Employees 0.07K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Mr. Nabeel P. Subainati CPA Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. - Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM
Ratings
AVGR ISRG BDX BDXA ALC RMD
Quant Rating Score 2 3 3 5 3 3
Quant Rating Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
AVGR ISRG BDX BDXA ALC RMD
Last Close $0.474 $493.72 $224.92 $59.24 $89.15 $225.79
High 52 $4.29 $610.45 $249.08 $59.24 $100.76 $257.65
Low 52 $0.38 $366.34 $220.02 $59.24 $77.58 $173.83
Price vs. 52 Week High -88.95 % -19.12 % -9.7 % 0 % -11.52 % -12.37 %
Price vs. 52 Week Low 24.74 % 34.77 % 2.23 % 0 % 14.91 % 29.89 %
Total Return
AVGR ISRG BDX BDXA ALC RMD
1 Month Return 3.04 % -16.26 % -0.41 % 0 % 1.12 % -4.57 %
3 Month Return -24.87 % -8.5 % -0.28 % 0 % 5.92 % -5.34 %
6 Month Return -59.83 % -0.06 % -4.49 % 0 % -11.52 % -9.94 %
9 Month Return -70.47 % 15.33 % -3.88 % 0 % -3.37 % 7.07 %
YTD Return -42.05 % -5.41 % -0.86 % 0 % 5.02 % -1.27 %
1 Year Return -84.71 % 26.79 % -5.42 % 0 % 1.16 % 16.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVGR ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.7 % 1.73 % 0.29 % 0.92 %
Dividend Paid and Capex Coverage Ration (TTM) -223.88 % 2.17 % 1.98 % 1.98 % 2.05 % 3.84 %
Dividend Per Share (TTM) - - 3.89 % 3.89 % 0.26 % 2.07 %
Payout Ratio (TTM) -0.35 % - 65.26 % 65.26 % 13.01 % 23.76 %
Profitability
AVGR ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 20.94 % 67.46 % 45.22 % 45.22 % 55.61 % 57.94 %
Return on Assets TTM -136.82 % 12.39 % 3.16 % 3.16 % 3.35 % 17.49 %
Return on Equity TTM -5425.36 % 15.31 % 6.73 % 6.73 % 6.43 % 25.05 %
Return on Capital Employed TTM -427.04 % 13.82 % 5.64 % 5.64 % 5.03 % 24.81 %
Net Income Per EBT TTM 100 % 86.87 % 88.43 % 88.43 % 81.05 % 81.35 %
EBT Per Ebit TTM 106.34 % 113.83 % 73.61 % 73.61 % 88.89 % 98.37 %
EBIT Per Revenue TTM -240.98 % 28.12 % 12.85 % 12.85 % 14.24 % 31.67 %
Cash Flow To Debt Ratio TTM -260.09 % - 19.46 % 19.46 % 36.06 % 175.81 %
Receivables Turnover TTM 8.28 6.16 7.82 7.82 4.77 5.73
Payables Turnover TTM 6.23 14.05 - - 5.7 9.41
Inventory Turnover TTM 1.53 1.83 2.93 2.93 1.94 2.35
Fixed Asset Turnover TTM 383.62 % 179.75 % 312.63 % 312.63 % 205.17 % 734.05 %
Asset Turnover TTM 53.39 % 44.56 % 37.76 % 37.76 % 32.71 % 68.99 %
Operating Cash Flow Per Share TTM -6.54 6.78 12.61 12.61 3.75 10.05
Free Cash Flow Per Share TTM -6.54 3.66 10.14 10.14 2.19 9.45
Cash Per Share TTM 265.33 % 1126.07 % 251.46 % 251.46 % 370.15 % 355.4 %
Operating Cash Flow Sales Ratio TTM -200.39 % 28.91 % 17.68 % 17.68 % 18.66 % 29.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 53.99 % 80.44 % 80.44 % 58.38 % 94.04 %
Cash Flow Coverage Ratios TTM -260.09 % - 19.46 % 19.46 % 36.06 % 175.81 %
Price To Free Cash Flows Ratio TTM -0.1 135.06 22.34 22.04 42.14 23.88
Price To Operating Cash Flows Ratio TTM -0.07 72.86 18.12 17.87 24.59 22.46
Price Cash Flow Ratio TTM -0.07 72.86 18.12 17.87 24.59 22.46
Income Statement (TTM)
AVGR ISRG BDX BDXA ALC RMD
Revenue $0.01B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 26.18% 67.5% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.02B $2.67B $4.85B $4.85B $2.68B $1.53B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -23.31 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
AVGR ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.02B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $-0.01B $16.53B $25.91B $25.91B $21.55B $4.86B
Total Investments $0B $6.81B $0.45B $0.45B $0.75B $0.17B
Total Debt $0.02B $0B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
AVGR ISRG BDX BDXA ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.84B $3.84B $2.08B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.62
ALC Alcon Inc. 89.22
ANGO AngioDynamics, Inc. 9.05
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.715
ATRC AtriCure, Inc. 33.39
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AZTA Azenta, Inc. 38.79
BAX Baxter International Inc. 35.08
BDX Becton, Dickinson and Company 225.97
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.405
BLFS BioLife Solutions, Inc. 26.41
COO The Cooper Companies, Inc. 80.51
DXR Daxor Corporation 7.9
EKSO Ekso Bionics Holdings, Inc. 0.3891
FEMY Femasys Inc. 1.49
GCTK GlucoTrack, Inc. 0.3564
ETFs With Exposure to AVGR
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 173.535
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.19
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.2
VEMPX Vanguard Extended Market Index InstlPlus 0 323.75
Unlock